Down syndrome screening in the first and second trimesters: What do the data show?

Seminars in Perinatology

Volumn 29, Issue 6, 2005, Pages 367-375

  Rosen, Todd ^a   D'Alton, Mary E ^a,b  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Down syndrome; Nasal bone; Nuchal translucency; Pregnancy; Prenatal diagnosis; Serum screening

Indexed keywords

BIOLOGICAL MARKER;

ALGORITHM; BLOOD ANALYSIS; CHEMICAL ANALYSIS; DOWN SYNDROME; DUCTUS VENOSUS; ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; INTERMETHOD COMPARISON; NUCHAL TRANSLUCENCY MEASUREMENT; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCREENING; SECOND TRIMESTER PREGNANCY; SENSITIVITY ANALYSIS; TRICUSPID VALVE REGURGITATION; ULTRASOUND;

ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; ESTRIOL; FEMALE; GESTATIONAL AGE; HUMANS; NASAL BONE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; QUALITY CONTROL; ULTRASONOGRAPHY, PRENATAL;

EID: 33644889373     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2006.01.001     Document Type: Review

References (53)

1. D.W. Bianchi, J.L. Simpson, L.G. Jackson Fetal gender and aneuploidy detection using fetal cells in maternal blood analysis of NIFTY I data National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn 22 2002 609 615
2. T.J. Mathews, B.E. Hamilton Mean age of mother, 1970-2000 Natl Vital Stat Rep 51 2002 1 13
3. J.A. Martin, B.E. Hamilton, P.D. Sutton Births final data for 2002 Natl Vital Stat Rep 52 2003 1 113
4. A.O. Odibo, D.M. Stamilio, D.B. Nelson A cost-effectiveness analysis of prenatal screening strategies for Down syndrome Obstet Gynecol 106 2005 562 568
5. N.J. Wald, A. Kennard, A. Hackshaw Antenatal screening for Down's syndrome J Med Screen 4 1997 181 246
6. N.J. Wald, C. Rodeck, A.K. Hackshaw First and second trimester antenatal screening for Down's syndrome the results of the Serum, Urine and Ultrasound Screening Study (SURUSS) Health Technol Assess 7 2003 1 77
7. F.D. Malone, J.A. Canick, R.H. Ball First and Second Trimester Evaluation of Risk for Fetal Aneuploidy (FASTER) Principal results of the NICHD Multicenter Down Syndrome Screening Study N Engl J Med 353 2005 2001 2011
8. K.H. Nicolaides, G. Azar, D. Byrne Fetal nuchal translucency ultrasound screening for chromosomal defects in first trimester of pregnancy Br Med J 304 1992 867 869
9. K.H. Nicolaides Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities Am J Obstet Gynecol 191 2004 45 67
10. F.D. Malone, R.L. Berkowitz, J.A. Canick First-trimester screening for aneuploidy research or standard of care? Am J Obstet Gynecol 182 2000 490 496
11. P.P. Pandya, A. Kondylios, L. Hilbert Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency Ultrasound Obstet Gynecol 5 1995 15 19
12. R.J. Snijders, P. Noble, N. Sebire Fetal Medicine Foundation First Trimester Screening Group UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation Lancet 352 1998 343 346
13. G. Moscoso Fetal nuchal translucency a need to understand the physiological basis Ultrasound Obstet Gynecol 5 1995 6 8
14. F.D. Malone, M.E. D'Alton First-trimester sonographic screening for Down syndrome Obstet Gynecol 102 2003 1066 1079
15. K. Avgidou, A. Papageorghiou, R. Bindra Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies Am J Obstet Gynecol 192 2005 1761 1767
16. R. Wapner, E. Thom, J.L. Simpson First-trimester screening for trisomies 21 and 18 N Engl J Med 349 2003 1405 1413
17. F. Scott, H. Peters, M. Bonifacio Prospective evaluation of a first trimester screening program for Down syndrome and other chromosomal abnormalities using maternal age, nuchal translucency and biochemistry in an Australian population Aust N Z J Obstet Gynaecol 44 2004 205 209
18. V.L. Souter, D.A. Nyberg Sonographic screening for fetal aneuploidy first trimester J Ultrasound Med 20 2001 775 790
19. J.A. Hyett, N.J. Sebire, R.J. Snijders Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency thickness Ultrasound Obstet Gynecol 7 1996 101 103
20. B.W. Mol, J.G. Lijmer, J. van der Meulen Effect of study design on the association between nuchal translucency measurement and Down syndrome Obstet Gynecol 94 1999 864 869
21. K. Spencer, R. Bindra, A.B. Nix Delta-NT or NT MoM which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester? Ultrasound Obstet Gynecol 22 2003 142 148
22. H.S. Bernstein, R.A. Filly, J.D. Goldberg Prognosis of fetuses with a cystic hygroma Prenat Diagn 11 1991 349 355
23. R. Ganapathy, M. Guven, F. Sethna Natural history and outcome of prenatally diagnosed cystic hygroma Prenat Diagn 24 2004 965 968
24. E.S. Howarth, E.S. Draper, J.L. Budd Population-based study of the outcome following the prenatal diagnosis of cystic hygroma Prenat Diagn 25 2005 286 291
25. M.P. Johnson, A. Johnson, W. Holzgreve First-trimester simple hygroma cause and outcome Am J Obstet Gynecol 168 1993 156 161
26. S. Miyabara, H. Sugihara, N. Maehara Significance of cardiovascular malformations in cystic hygroma a new interpretation of the pathogenesis Am J Med Genet 34 1989 489 501
27. A. Nadel, B. Bromley, B.R. Benacerraf Nuchal thickening or cystic hygromas in first- and early second-trimester fetuses prognosis and outcome Obstet Gynecol 82 1993 43 48
28. L.P. Shulman, D.S. Emerson, R.E. Felker High frequency of cytogenetic abnormalities in fetuses with cystic hygroma diagnosed in the first trimester Obstet Gynecol 80 1992 80 82
29. Y. Sorokin, M.P. Johnson, A. Drugan Amniotic fluid alpha-fetoprotein levels in the differential diagnosis of cystic hygroma Fetal Ther 4 1989 178 184
30. R.M. van Zalen-Sprock, J.M. van Vugt, H.P. van Geijn First-trimester diagnosis of cystic hygroma-course and outcome Am J Obstet Gynecol 167 1992 94 98
31. P. Taipale, V. Hiilesmaa, R. Salonen Increased nuchal translucency as a marker for fetal chromosomal defects N Engl J Med 337 1997 1654 1658
32. F.D. Malone, R.H. Ball, D.A. Nyberg First-trimester septated cystic hygroma prevalence, natural history, and pediatric outcome Obstet Gynecol 106 2005 288 294
33. L.J. Down Observations on an ethnic classification of idiots Clinical Lectures and Reports, London Hospital 3 1866 259 262
34. S. Cicero, P. Curcio, A. Papageorghiou Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation an observational study Lancet 358 2001 1665 1667
35. A.O. Odibo, H.M. Sehdev, L. Dunn The association between fetal nasal bone hypoplasia and aneuploidy Obstet Gynecol 104 2004 1229 1233
36. F. Orlandi, C.M. Bilardo, M. Campogrande Measurement of nasal bone length at 11-14 weeks of pregnancy and its potential role in Down syndrome risk assessment Ultrasound Obstet Gynecol 22 2003 36 39
37. F. Prefumo, F. Sethna, S. Sairam First-trimester ductus venosus, nasal bones, and Down syndrome in a high-risk population Obstet Gynecol 105 2005 1348 1354
38. E. Viora, B. Masturzo, G. Errante Ultrasound evaluation of fetal nasal bone at 11 to 14 weeks in a consecutive series of 1906 fetuses Prenat Diagn 23 2003 784 787
39. M.A. Zoppi, R.M. Ibba, C. Axiana Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies Prenat Diagn 23 2003 496 500
40. F.D. Malone, R.H. Ball, D.A. Nyberg First-trimester nasal bone evaluation for aneuploidy in the general population Obstet Gynecol 104 2004 1222 1228
41. S. Cicero, V. Dezerega, E. Andrade Learning curve for sonographic examination of the fetal nasal bone at 11-14 weeks Ultrasound Obstet Gynecol 22 2003 135 137
42. A. Matias, N. Montenegro, J.C. Areias Anomalous fetal venous return associated with major chromosomopathies in the late first trimester of pregnancy Ultrasound Obstet Gynecol 11 1998 209 213
43. K.H. Nicolaides, K. Spencer, K. Avgidou Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening Ultrasound Obstet Gynecol 25 2005 221 226
44. I.C. Huggon, D.B. DeFigueiredo, L.D. Allan Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11-14 weeks of gestation Heart 89 2003 1071 1073
45. I.R. Merkatz, H.M. Nitowsky, J.N. Macri An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities Am J Obstet Gynecol 148 1984 886 894
46. J.E. Haddow, G.E. Palomaki, G.J. Knight Screening of maternal serum for fetal Down's syndrome in the first trimester N Engl J Med 338 1998 955 961
47. M.L. Brizot, R.J. Snijders, N.A. Bersinger Maternal serum pregnancy-associated plasma protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy Obstet Gynecol 84 1994 918 922
48. M.L. Brizot, R.J. Snijders, J. Butler Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy Br J Obstet Gynaecol 102 1995 127 132
49. N.J. Wald, H.C. Watt, A.K. Hackshaw Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters N Engl J Med 341 1999 461 467
50. H.W. Lawson, A. Frye, H.K. Atrash Abortion mortality, United States, 1972 through 1987 Am J Obstet Gynecol 171 1994 1365 1372
51. A. Herman, E. Dreazen, J. Tovbin Comparison between disclosure and non-disclosure approaches for trisomy 21 screening tests Hum Reprod 17 2002 1358 1362
52. J.A. Copel, R.O. Bahado-Singh Prenatal screening for Down's syndrome a search for the family's values N Engl J Med 341 1999 521 522
53. H. Cuckle, P. Benn, D. Wright Down syndrome screening in the first and/or second trimester model predicted performance using meta-analysis parameters Semin Perinatol 29 2005 252 257